Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

The unit area trichogram is a reliable method to assess hair loss and treatment response in people with androgenic alopecia by measuring hair density and thickness.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Some birth control pills have a higher risk of blood clots than others.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Researchers developed a method to detect hormone-blocking drugs in wastewater and found them in Beijing's sewage, suggesting they can survive sewage treatment.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Birth control pills can help manage acne, but dermatologists should know their skin-related side effects, especially when prescribing drugs that can harm unborn babies.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Early diagnosis and treatment, like topical minoxidil, can prevent hair loss in children.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Early detection and comprehensive treatment of PCOS are crucial due to its long-term health impacts and associated risks.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.